(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 99.83% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.14%, and it is also forecast to beat the US market's average forecast revenue growth rate of 59.56%.
Neuronetics's revenue in 2025 is $74,890,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2025 to be $9,849,141,721, with the lowest STIM revenue forecast at $9,727,384,874, and the highest STIM revenue forecast at $9,970,898,568.
In 2026, STIM is forecast to generate $10,658,331,146 in revenue, with the lowest revenue forecast at $10,654,711,348 and the highest revenue forecast at $10,661,950,944.